Acelyrin Cash Flow Statement

Financials in millions CAD. Fiscal year is February - January.

Millions CAD. Fiscal year is Feb - Jan.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr '25 Apr 30, 2025	Jan '25 Jan 31, 2025	Jan '24 Jan 31, 2024	Jan '23 Jan 31, 2023	Jan '22 Jan 31, 2022	Jan '21 Jan 31, 2021
Net Income	-0.72	-0.81	-1.32	-1.47	-11.25	-0.8
Depreciation & Amortization	-	-	-	-	0.01	-
Provision & Write-off of Bad Debts	0	0	0	-	-	-
Other Operating Activities	0.02	0.03	0.04	0.01	8.04	-
Change in Accounts Receivable	0.15	0.16	-0.07	-0.05	-0.07	-0.03
Change in Inventory	-0.08	0	0.01	0.22	-0.33	-
Change in Accounts Payable	0.58	0.66	0.56	0.4	0.19	0.09
Change in Other Net Operating Assets	0.03	-0	-0.01	0.07	-0.11	-
Operating Cash Flow	-0.02	0.04	-0.79	-0.84	-3.54	-0.74
Cash Acquisitions	-	-	-	-	0.94	-
Investing Cash Flow	-	-	-	-	0.94	-
Long-Term Debt Issued	-	-	0.5	0.21	-	-
Long-Term Debt Repaid	-	-	-0.33	-	-0.43	-
Net Debt Issued (Repaid)	-	-	0.18	0.21	-0.43	-
Issuance of Common Stock	-	-	0.55	0.09	1.18	6.02
Other Financing Activities	-	-	-	-	-	0.7
Financing Cash Flow	-	-	0.72	0.3	0.75	6.72
Net Cash Flow	-0.02	0.04	-0.06	-0.54	-1.85	5.98
Levered Free Cash Flow	0.27	0.37	-0.27	-0.27	-3.21	-
Unlevered Free Cash Flow	0.27	0.37	-0.26	-0.27	-3.21	-
Change in Working Capital	0.67	0.81	0.5	0.63	-0.33	0.06

Updated Dec 13, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.